42 results match your criteria: "GZO - Zurich Regional Health Center[Affiliation]"
Inflamm Intest Dis
August 2020
Department of Health Sciences, Helsana Group, Zurich, Switzerland.
Background: Postoperative recurrence is frequently observed after ileocecal resection in Crohn's disease (CD) patients. Since 2010, endoscopy within 1 year is considered the gold standard for its diagnosis. However, if and how frequent such endoscopies are performed in clinical practice remains unknown.
View Article and Find Full Text PDFGut
April 2021
Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
Extraintestinal manifestations (EIMs) are frequently observed in IBDs and contribute considerably to morbidity and mortality. They have long been considered a difficult to treat entity due to limited therapy options, but the increasing use of anti-tumour necrosis factors has dramatically changed the therapeutic approach to EIM in recent years. Newly emerging therapies such as JAK inhibitors and anti-interleukin 12/23 will further shape the available armamentarium.
View Article and Find Full Text PDFDigestion
August 2021
Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Background: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily of, but not restricted to, the gut. Association between IBD and cancer has been clearly established and is uniformly accepted.
Summary: IBD patients are at particular risk for intestinal and extraintestinal cancers.
Clin Gastroenterol Hepatol
December 2021
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Background & Aims: Data evaluating efficacy of different doses of swallowed topical corticosteroids (STC) in the long-term management of eosinophilic esophagitis (EoE) are lacking. We assessed long-term effectiveness and safety of different STC doses for adults with EoE after achievement of histological remission.
Methods: We performed a retrospective multicenter study at five EoE referral centers (US and Switzerland).
Int Immunopharmacol
October 2020
Department of Molecular Mechanisms of Disease (DMMD), University of Zurich, Switzerland; Department of Clinical Immunology, University Hospital Zurich, Switzerland. Electronic address:
C-Cbl-associated protein (CAP), also known as Sorbin and SH3 domain-containing protein 1 (Sorbs1) or ponsin, an adaptor protein of the insulin-signalling pathway, mediates anti-viral and anti-cytotoxic protection in acute viral heart disease. In the present study we describe a novel protective immuno-modulatory function of CAP in inflammation. Among the three members of the Sorbs family of adapter molecules, which include CAP (Sorbs1), ArgBP2 (Sorbs2), and Vinexin (Sorbs3), CAP consistently down-regulated the expression of pro-inflammatory cytokines in mouse fibroblasts, cardiomyocytes, and myeloid-derived leukocytes, after Toll-like receptor (TLR) stimulation.
View Article and Find Full Text PDFFront Med (Lausanne)
June 2020
Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
SF68® (SF68) is a licensed pharmaceutical for treatment and prevention of diarrhea in Austria, Italy and Switzerland. However, as for other probiotics, evidence for its efficacy is based on small to medium-sized studies. Four unpublished studies on the treatment of acute diarrhea and the prevention of antibiotic-associated diarrhea were analyzed: one randomized, double blind, placebo-controlled trial (RCT) for treatment ( = 1,143), one open-label study for treatment ( = 5,093), one RCT for prevention ( = 1,397) and one open-label study for prevention ( = 4,340).
View Article and Find Full Text PDFESC Heart Fail
October 2020
Department of Cardiology, University Heart Center Zurich, Raemistr. 100, Zurich, 8091, Switzerland.
Aims: Cardiac resynchronization therapy (CRT) has become an important therapy in patients with heart failure with reduced left ventricular ejection fraction (LVEF). The effect of diabetes on long-term outcome in these patients is controversial. We assessed the effect of diabetes on long-term outcome in CRT patients and investigated the role of diabetes in ischaemic and non-ischaemic cardiomyopathy.
View Article and Find Full Text PDFBasic Res Cardiol
December 2019
Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland.
Heart-specific CD4 T cells have been implicated in development and progression of myocarditis in mice and in humans. Here, using mouse models of experimental autoimmune myocarditis (EAM) we investigated the role of heart non-specific CD4 T cells in the progression of the disease. Heart non-specific CD4 T cells were obtained from DO11.
View Article and Find Full Text PDFClin Gastroenterol Hepatol
September 2020
Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland; Department of Medicine, GZO - Zurich Regional Health Center, Wetzikon, Switzerland. Electronic address:
Background & Aims: It is not clear how rapid ascent to a high altitude causes the gastrointestinal symptoms of acute mountain sickness (AMS). We assessed the incidence of endoscopic lesions in the upper gastrointestinal tract in healthy mountaineers after a rapid ascent to high altitude, their association with symptoms, and their pathogenic mechanisms.
Methods: In a prospective study, 25 mountaineers (10 women; mean age, 43.
J Immunol Res
November 2018
Cardioimmunology, Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.
Myocarditis is an important cause of heart failure in young patients. Autoreactive, most often, infection-triggered CD4 T cells were confirmed to be critical for myocarditis induction. Due to a defect in clonal deletion of heart-reactive CD4 T cells in the thymus of mice and humans, significant numbers of heart-specific autoreactive CD4 T cells circulate in the blood.
View Article and Find Full Text PDFEndoscopy
February 2017
Department of Medicine, GZO - Zurich Regional Health Center, Wetzikon, Switzerland.
Oncol Lett
October 2016
Department of Medicine, GZO-Zurich Regional Health Center, 8620 Wetzikon, Zurich, Switzerland.
In the present study, the case of a 41-year-old man with immunoglobulin (Ig)M multiple myeloma (MM) that presented with an unusually non-aggressive clinical course who has survived for >9 years to date, is presented. Initial diagnosis of symptomatic MM was established according to the International Myeloma Working Group consensus statement and guidelines. Due to the mild symptoms, no therapy was administered and the patient was closely followed up.
View Article and Find Full Text PDFJ Clin Gastroenterol
December 2018
Departments of *Medicine †Surgery, GZO-Zurich Regional Health Center, Wetzikon, Switzerland.
Eur J Immunol
August 2016
Institute for Experimental Immunology and Imaging, University Hospital, University Duisburg-Essen, Essen, Germany.
To assess the role of alveolar macrophages (AMs) during a pulmonary Aspergillus fumigatus infection AMs were depleted by intratracheal application of diphtheria toxin (DTX) to transgenic CD11c.DTR mice prior to fungal infection. Unexpectedly, all CD11c.
View Article and Find Full Text PDFPLoS One
July 2017
Cardioimmunology, Center of Molecular Cardiology, University of Zurich, Wagistr. 12, CH-8952, Schlieren, Switzerland.
Rationale: Perioperative myocardial ischemia is common in high-risk patients. The use of interventional revascularisation or even thrombolysis is limited in this patient subset due to exceedingly high bleeding risks. Blockade of voltage-gated sodium channels (VGSC) with lidocaine had been suggested to reduce infarct size and cardiomyocyte cell death in ischemia/reperfusion models.
View Article and Find Full Text PDFEur Heart J
May 2017
Research of Systemic Autoimmune Diseases, Division of Rheumatology, University Hospital Zurich, Wagistr. 14, CH-8952 Schlieren, Switzerland.
Aims: Myocardial fibrosis critically contributes to cardiac dysfunction in inflammatory dilated cardiomyopathy (iDCM). Activation of transforming growth factor-β (TGF-β) signalling is a key-step in promoting tissue remodelling and fibrosis in iDCM. Downstream mechanisms controlling these processes, remain elusive.
View Article and Find Full Text PDFEur Heart J
August 2014
Division of Cardiology, GZO-Zurich Regional Health Center, Wetzikon, Switzerland Cardioimmunology, Center of Molecular Cardiology, University of Zurich, Zurich, Switzerland